Kenneth A. Schultz, M.D., Vice President of Innovation, Strategy and Business Development

Kenneth A. Schultz, M.D., joined Halozyme in January 2015 as Vice President of Innovation, Strategy and Business Development. From 2013-2014, Dr. Schultz held roles of increasing responsibility with Medtronic Diabetes, where he most recently served as Chief of Staff, Strategy, and Business Development and was responsible for identifying and evaluating novel therapies to purchase, entering the type 2 diabetes market, pursuing comprehensive partnerships, creating new service line strategies, and pursuing external investments. Prior to his role at Medtronic Diabetes, Dr. Schultz worked at McKinsey & Company from 2007-2012, where he provided consultative services to a range of global organizations across the medical device and pharmaceutical sectors. Dr. Schultz received his medical degree from Texas Tech University, an MBA from IMD in Switzerland and a bachelor’s degree from the Texas A&M University. Dr. Schultz began his career as a practicing physician. From 1999-2005, he worked in various positions including Vice-Chairman of Emergency Medicine with EMCare Physicians.


You are now leaving Halozyme is not responsible for or endorses the content of the linked site.